Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02203877|
Recruitment Status : Completed
First Posted : July 30, 2014
Last Update Posted : August 12, 2016
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||August 2015|
|Actual Study Completion Date :||August 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Crepinsek MA, Taylor EA, Michener K, Stewart F. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2020 Sep 29;9:CD007239. doi: 10.1002/14651858.CD007239.pub4.
Pastor-Villaescusa B, Hurtado JA, Gil-Campos M, Uberos J, Maldonado-Lobón JA, Díaz-Ropero MP, Bañuelos O, Fonollá J, Olivares M; PROLAC Group. Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women. Benef Microbes. 2020 May 11;11(3):235-244. doi: 10.3920/BM2019.0180. Epub 2020 Mar 27.